A MicroRNA-regulated and GP64-pseudotyped Lentiviral Vector Mediates Stable Expression of FVIII in a Murine Model of Hemophilia A

Overview of attention for article published in Molecular Therapy, February 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

patent: 15 patents

Readers on

mendeley: 91 Mendeley

So far, Altmetric has seen 15 patents that reference this research output.

Virus vector production

Grant US-12359217-B2

United States of America

15 Jul 2025

Methods and compositions for modified factor IX fusion proteins

Grant US-12304944-B2

United States of America

20 May 2025

NOVEL LENTIVIRAL VECTOR PARTICLES

Application WO-2025051860-A1

World Intellectual Property Organisation (WIPO)

13 Mar 2025

NOVEL LENTIVIRAL VECTOR PARTICLES

Application EP-4520831-A1

European Patent Office

12 Mar 2025

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 11 additional patents.